Revolution Medicines trades at 18x–58x projected 2027 U.S. revenue scenarios, leading to a Hold rating despite robust ...

Vaxcyte stays a Strong Buy after VAX-31 phase 3 OPUS-1 success; broader pneumococcal coverage and 2027 catalysts are ahead.

In other words, everyone was standing on the same side of the boat. Ether's spot price fell about 4.8% to roughly $2,568 ...

The United States has delivered its first fully American-made Tamir interceptor missile to Israel following production and assembly at the Raytheon-Rafael facility in East Camden, Arkansas, ...

Anthropic targets a mid-October roadshow on Nasdaq, according to Reuters, and OpenAI has postponed its listing to 2027 via ...

Oshawa Assembly will keep building pickup trucks, but one of the products that helped revive the historic Ontario factory is ...

Choosing an AI image tool from a gallery is like choosing a camera by looking at someone else’s vacation photos. The examples ...

The Airbus A350F will make its first flight on 29 September, after MSN700 completed two high-speed rejected-takeoff tests in ...

A handheld near-infrared spectrometer combined with a new bilinear surface model and covariance-guided sampling predicts five ...

Executive Editor Brian Sozzi takes a look at the biggest stories as the trading day kicks off, weighing in on what's next for SpaceX (SPCX), airline earnings expectations, and more.Sozzi also sits ...

Software names usually give users at least a small clue about what they are looking at. A browser may sound like a bro ...